Alejandro Jimenez-Munoz

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort.

Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort.

Journal: Lupus science & medicine
Published: April 13, 2025

Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

Journal: Rheumatology (Oxford, England)
Published: January 16, 2024

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.

Journal: Lupus science & medicine
Published: November 09, 2023

Clustering of systemic lupus erythematosus mortality in southwestern Spain.

Clustering of systemic lupus erythematosus mortality in southwestern Spain.

Journal: Lupus
Published: August 29, 2023

Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.

Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.

Journal: Rheumatology (Oxford, England)
Published: August 24, 2023

Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.

Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.

Journal: Clinical and experimental rheumatology
Published: September 27, 2022

Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.

Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.

Journal: Clinical and experimental rheumatology
Published: August 21, 2022

Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.

Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.

Journal: Clinical and experimental rheumatology
Published: July 17, 2021

The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.

The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.

Journal: Clinical and experimental rheumatology
Published: November 25, 2020

Trends in mortality from lupus in Spain from 1980 to 2018.

Trends in mortality from lupus in Spain from 1980 to 2018.

Journal: Lupus
Published: August 26, 2020

Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association.

Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association.

Journal: Seminars in arthritis and rheumatism
Published: April 05, 2020

Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19

Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19

Journal: Reumatologia clinica
Published: March 25, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026